NCT05049759

Brief Summary

Prevalence of mental health problems and disorders in children and adolescents (hereafter youths) are estimated at 13.4% of which anxiety and depressive disorders account for more than half of these disorders. These rates are increasing, putting a large strain on child and adolescent mental healthcare services (CAMHS) to provide cost-effective treatments with documented long-term effects. However, even when provided the best evidence based treatment, between 40-50 % do not recover and continue to report significant symptom burdens. Thus, there is an immediate need for supplementary and/or new treatment approaches. Physical activity as a supplementary treatment may be one such approach. However, research investigating this approach within this population is scant. This protocol paper describes the development and feasibility trial of a physical activity based intervention targeting anxiety and depressive symptoms in youth. The current study will be based on the UK Medical Council Research Framework (MRC) for developing and evaluating complex interventions. The study will initially focus on the first two phases of the MRC framework. In line with phase one of this framework, key intervention components have been identified in preliminary work, which draw on the effects of moderate to vigorous physical activity, inhibitory learning theory and self determination theory. These components are to be developed into an intervention to be used in CAMHS. Twenty youths with anxiety and/or depressive symptoms will be recruited to the intervention. Physical activity will be measured using the Actigraph GT3X+ monitor at baseline and post-intervention. Outcome measures concerning symptom change will be assessed (anxiety and depression). Semi-structured qualitative interview with participants, caregivers and referring specialists will help identify possible contextual and practical factors associated with delivery of the intervention and explore acceptability of assessment procedures, the intervention, and perceived benefits and barriers to participation. This study will contribute to the development of evidence-based, patient-informed supplementary physical treatment interventions for youth with internalizing disorders in contact with CAMHS. The goal is to examine new avenues of treatment that ultimately may improve upon current treatment outcomes of these disorders.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable anxiety

Timeline
Completed

Started Jul 2021

Typical duration for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 19, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

September 20, 2021

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2022

Completed
Last Updated

March 12, 2024

Status Verified

March 1, 2024

Enrollment Period

1.3 years

First QC Date

August 19, 2021

Last Update Submit

March 7, 2024

Conditions

Keywords

AnxietyDepressionPhysical ActivityYouth

Outcome Measures

Primary Outcomes (6)

  • Objective measure of activity change

    Actigraph measurement of youth activity level

    Pre-treatment, post-treatment (max. 2 weeks following end of treatment) and six months post treatment (long-term)

  • Anxiety symptom change

    Spence Child Anxiety Scale, child and parent version (SCAS-C/P). The measure assesses youth anxiety symptoms. The SCAS-C/P comprises 38 items rated on a 4-point scale (0 = never, 1 = sometimes, 2 = often, 3 = always), with possible a minimum score of 0 and possible a maximum score of 114. High scores indicate higher anxiety levels, and lower scores indicate lower anxiety levels.

    Pre-treatment, post-treatment (max. 2 weeks following end of treatment) and six months post treatment (long-term)

  • Affective symptom change

    Short Mood and Feelings Questionnaire, child and parent version (SMFQ-C/P). The measure assesses youth depressive symptoms. The SMFQ consists of 13 items rated on a 3-point scale (0 = not true, 1 = sometimes true, 2 = true), with possible a minimum score of 0 and possible maximum score of 26.Higher scores indicate greater severity of depressive symptoms.

    Pre-treatment, post-treatment (max. 2 weeks following end of treatment) and six months post treatment (long-term)

  • Recruitment rate (number of youth referred/number of youth assessed as eligible).

    These descriptive data provide information concerning the feasibility of the program. Tracking of participant recruitment (number of youth referred/number of youth assessed as eligible), Rates will be presented in percent.

    Pre-treatment

  • Attendance rate (total number of sessions youth attend)

    These descriptive data provide information concerning the feasibility of the program. Attendance to the intervention was measured by counting how many sessions each participant attended and then dividing it by the total number of exercise sessions. Attendance is presented as a percent.

    From start of treatment to end of treatment (7 weeks)

  • Retention rate (number of sessions youth completed before their last session)

    These descriptive data provide information concerning the feasibility of the program. Retention rate is defined as the number of participants who remained in the study, i.e. the number of participants who did not drop out.

    From start of treatment to end of treatment (7 weeks)

Secondary Outcomes (1)

  • Key-process-related outcome e.g how did the participant experience the treatment.

    Through study completion, an average of 1 year

Study Arms (1)

Feasibility testing

EXPERIMENTAL

The feasibility trial, aims to assess the feasibility of the intervention, including assessment of acceptability and outcome measures. Twenty youths with anxiety and/or depressive symptoms will be recruited to the intervention. Physical activity will be measured using the Actigraph GT3X+ monitor at baseline and post-intervention. Outcome measures concerning symptom change will be assessed (anxiety and depression). Semi-structured qualitative interview with participants, caregivers and referring specialists will help identify possible contextual and practical factors associated with delivery of the intervention and explore acceptability of assessment procedures, the intervention, and perceived benefits and barriers to participation.

Behavioral: Confident, Active and Happy Youth

Interventions

The three target goals of the intervention (confident, active and happy) link closely to the core symptoms of internalizing disorders. Thus, a core symptom of anxiety is a lack of confidence in one's ability to cope with a given fearful situation. The ensuing behavioral reaction is avoidance of the situation and/or enduring it with excessive discomfort. Similarly, a core symptom of a depressive disorder is lowered mood. Regarding both depression and anxiety, both disorders are associated with less physical activity, and low levels of physical activity conversely help maintain the disorders. As such, the aim is to alleviate symptoms and supplement ongoing treatment in CAMHS.

Also known as: CAH-Y
Feasibility testing

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age 8- 17 years
  • Symptoms of anxiety and/or depression
  • Youth display reduced daily physical activity (less than 30 mins. pr. day and/or does not partake in physical leisure activities, and/or does not participate in physical education in school).
  • The youth is motivated to partake in physical activity

You may not qualify if:

  • Physical activity is not advised for medical reasons
  • Severe learning disabilities and the youth is unable to understand the study protocol
  • Specific psychiatric disorders including any eating disorder, psychosis
  • Severe challenging behavior or other needs requiring constant one to one support

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Haukeland University Hospital

Bergen, 5021, Norway

Location

Related Publications (3)

  • Anker EA, Boe Sture SE, Hystad SW, Kodal A. The effect of physical activity on anxiety symptoms among children and adolescents with mental health disorders: a research brief. Front Psychiatry. 2024 May 13;15:1254050. doi: 10.3389/fpsyt.2024.1254050. eCollection 2024.

  • Kodal A, Muirhead F, Reilly JJ, Wergeland GJ, Thorsen PJB, Bovim LP, Elgen IB. Feasibility of a physical activity intervention for children and adolescents with anxiety and depression. Pilot Feasibility Stud. 2024 Mar 5;10(1):49. doi: 10.1186/s40814-024-01466-8.

  • Kodal A, Muirhead F, Reilly JJ, Wergeland GJH, Thorsen PJB, Bovim LP, Elgen IB. Development and feasibility testing of a physical activity intervention for youth with anxiety and depression: a study protocol. Pilot Feasibility Stud. 2022 Mar 2;8(1):48. doi: 10.1186/s40814-022-01010-6.

MeSH Terms

Conditions

Anxiety DisordersDepressionMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Arne Kodal, PhD

    Haukeland University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Feasibility trial to establish acceptability and feasibility of the developed intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2021

First Posted

September 20, 2021

Study Start

July 1, 2021

Primary Completion

November 1, 2022

Study Completion

November 1, 2022

Last Updated

March 12, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Data are relevant for feasibility testing, thus not assessed relevant for IPD.

Locations